State of Alaska, Department of Revenue
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 1370102
JUNEAU, AK
Position in PLX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$50,866
+$3,493 QoQ
Shares Held
21,831
0.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 101 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026State of Alaska, Department of Revenue holds $93,905,322 across 47 Biotechnology names. PLX ranks #43 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
31,836 | $15,813,895 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
142,422 | $11,147,368 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,215 | $10,734,240 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
38,357 | $9,242,885 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
13,385 | $4,974,801 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
40,107 | $3,487,302 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
28,084 | $3,442,536 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
62,402 | $3,428,365 |
All Filings in PLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,866 | 21,831 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $47,373 | 21,831 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $39,295 | 21,831 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||